Dexcom CGM users will be able to see CGM data
on Fitbit Ionic™ providing a convenient and discreet way to track
glucose levels on wrist for users of both Android and iOS
devices
Fitbit (NYSE:FIT), the leading global wearables brand,
and DexCom, Inc. (NASDAQ:DXCM), the leader in continuous
glucose monitoring (CGM) for people with diabetes, today announced
a collaboration to develop and market products to help people
better manage their diabetes and get a more complete picture of
their overall health with easy-to-use mobile tools.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170907005577/en/
The first planned initiative is to bring Dexcom CGM data to
Fitbit’s new smartwatch, Fitbit Ionic. Through this experience,
Dexcom CGM users on either Android or iOS devices would be able to
see both activity and glucose levels, right on their wrist.
“The strength of our brand and our ability to track critical
health metrics continuously for up to 4+ days1, coupled with
Dexcom’s market leadership in CGM, present a powerful combination
that we hope will help millions of people better manage their
diabetes,” said James Park, CEO of Fitbit. “With Ionic, we are
focused on driving positive health outcomes and more health focused
tools, and this collaboration is a wonderful example of how we plan
to bring that vision to our users.”
Dexcom CGM Display on Fitbit Ionic will provide data
for those living with diabetes
The World Health Organization estimates2 that more than 400
million people around the world are living with diabetes. For those
individuals being able to see both physical activity and glucose
can be a vital tool for effectively managing their diabetes.
“The collaboration between Dexcom and Fitbit is an important
step in providing useful information to people with diabetes that
is both convenient and discreet,” said Kevin Sayer, President and
CEO, Dexcom. “We believe that providing Dexcom CGM data on Fitbit
Ionic, and making that experience available to users of both
Android and iOS devices, will have a positive impact on the way
people manage their diabetes.”
A health and fitness first platform, Ionic offers a highly
personalized experience not previously seen in other smartwatches.
Ionic features a relative SpO2 sensor, industry-leading GPS
tracking, on-device dynamic workouts, improved heart rate tracking,
and water resistance up to 50 meters. Plus, smart features like
contactless payments, on-board music, smart notifications, and a
variety of popular apps and clock faces available in the Fitbit App
Gallery. Ionic also has all the core features from Fitbit like 4+
day battery life, automatic activity and sleep tracking, and
cross-platform compatibility.
In addition to the Dexcom CGM display for Fitbit Ionic, with
Fitbit’s in-app Community, Dexcom CGM users will now be able to
connect with millions of people, where they can ask questions, seek
support and share successes in managing their health.
The companies are targeting availability as soon as possible in
2018 and will continue to explore opportunities to work together to
develop tools and resources aimed at helping people better manage
their diabetes.
About Fitbit, Inc. (NYSE:FIT)
Fitbit helps people lead healthier, more active lives by
empowering them with data, inspiration and guidance to reach their
goals. As the leading global wearables
brand, Fitbit designs products and experiences that track
and provide motivation for everyday health and fitness. Fitbit’s
diverse line of innovative and popular products
includes Fitbit Surge®, Fitbit Blaze®, Fitbit Charge
2®, Alta HR™, Alta®, Fitbit Flex
2®, Fitbit One® and Fitbit Zip® activity
trackers, as well as
the Fitbit Ionic™ smartwatch, Fitbit Flyer™ wireless
headphones and Fitbit Aria® and Fitbit Aria 2™ Wi-Fi
Smart Scales. Fitbit products are carried in 55,000
retail stores across 65 countries around the globe. Powered by one
of the world’s largest social fitness networks and databases of
health and fitness data, the Fitbit platform delivers
personalized experiences, insights and guidance through leading
software and interactive tools, including
the Fitbit and Fitbit Coach apps, Guided Health
Programs, and the Fitbit OS for smartwatches. Fitbit Health
Solutions develops health and wellness solutions designed to help
increase engagement, improve health outcomes, and drive a positive
return for employers, health plans and health systems.
Fitbit and the Fitbit logo are trademarks or
registered trademarks of Fitbit, Inc. in the U.S. and
other countries. Additional Fitbit trademarks can be found
at www.fitbit.com/legal/trademark-list. Third-party trademarks
are the property of their respective owners.
Connect with us
on Facebook, Instagram or Twitter and
share your Fitbit experience.
About DexCom, Inc. (NASDAQ:DXCM)
DexCom, Inc., headquartered in San Diego, CA, is dedicated
to helping people better manage their diabetes by developing and
marketing continuous glucose monitoring (CGM) products and tools
for adult and pediatric patients. With exceptional performance,
patient comfort and lifestyle flexibility at the heart of its
technology, users have consistently ranked Dexcom highest in
customer satisfaction and loyalty. For more information, visit
www.dexcom.com.
Forward-Looking Statements
This press release contains forward-looking statements, within
the meaning of the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995, that involve risks and uncertainties
including, among other things, statements regarding the future
availability of DexCom CGM data on Fitbit Ionic, the development of
products that allow people to better manage their diabetes, and the
future availability of Fitbit Ionic product features including the
Fitbit App Gallery and available apps. These forward-looking
statements are only predictions and may differ materially from
actual results due to a variety of factors, including the effects
of the highly competitive market in which our respective companies
operate, as more fully discussed under the heading “Risk Factors”
in each of our most recent reports on Form 10-Q filed with
the Securities and Exchange Commission. All forward-looking
statements contained herein are based on information available to
us as of the date hereof and we do not assume any obligation to
update these statements as a result of new information or future
events.
1 Battery life varies with use and other factors.
2 World Health Organization, Diabetes Fact Sheet, updated July
2017, accessed August 31, 2017:
http://www.who.int/mediacentre/factsheets/fs312/en/
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170907005577/en/
Fitbit, Inc.Jen Ralls, 415-941-0037PR@fitbit.comorDexCom,
Inc.Media ContactMelissa Katz,
215-514-0957mkatz@stonyhillcomms.comorInvestor ContactSteven Pacelli,
858-200-0200spacelli@dexcom.com
Fitbit (NYSE:FIT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Fitbit (NYSE:FIT)
Historical Stock Chart
From Jul 2023 to Jul 2024